Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall

Table 1

Patient, disease, and treatment characteristics between patients who underwent UE and PE.

Variable	All patients	Planned excision	Unplanned excision
Number	245	211	34
Median age	57	57	64
Median tumor Size	7.9 cm	8.5 cm	4 cm
Stage	I: 46 (18.7%); II: 62 (25.3%); III: 137 (56%)	I: 40 (19%); II: 46 (22%); III: 125 (59%)	I: 6 (17.7%); II: 16 (47%); III: 12 (35.3%)
Grade	Low: 47 (19.1%); Intermediate: 20 (8.2%); High: 178 (72.7%)	Low: 45 (18.4%); Intermediate: 15 (6.1%); High: 185 (75.5%)	Low: (3%); Intermediate: 5 (14.7%); High: 28 (82.3%)
Histology	Undifferentiated: 56 (22.9%); Leiomyosarcoma/liposarcoma: 77 (31.4%); Synovial: 45 (18.4%); Other: 67 (27.3%)	Undifferentiated: 51 (24.1%); Leiomyosarcoma/liposarcoma: 68 (32.2%); Synovial: 38 (18%); Other: 48 (22.7%)	Undifferentiated: 6 (17.6%); Leiomyosarcoma/liposarcoma: 9 (26.5%); Synovial: 7 (20.6%); Other: 12 (35.3%)
Tumor location	Upper extremity: 64 (26.1%); Lower extremity: 181 (73.9%)	Upper extremity: 50 (23.7%); Lower extremity: 161 (76.3%)	Upper extremity: 13 (38.2%); Lower extremity: 21 (61.8%)
Subcutaneous disease (TXa)	45 (18.4%)	36 (17%)	9 (26.5%)
Timing of RT	No RT: 36 (14.7%); Preoperative: 174 (71%); Postoperative: 35 (14.3%)	No RT: 24 (11.4%); Preoperative: 163 (77.2%); Postoperative: 24 (11.4%)	No RT: 12 (35.4%); Preoperative: 11 (32.3%); Postoperative (alone or after reexcision): 11 (32.3%)
Chemotherapy	68 (28%)	67 (32%)	1 (3%)